Literature DB >> 31558785

Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions.

Na-Yi Yuan Wu1, Chao Fang2, Hsuan-Shun Huang3, Jing Wang4, Tang-Yuan Chu5,6.   

Abstract

High-grade serous carcinoma is the most common and devastating type of ovarian cancer; its etiology, mechanism of malignant transformation, and origin remain controversial. Recent studies have identified secretory cells at the fimbria of the fallopian tube as the cell-of-origin of high-grade serous carcinoma, acquiring TP53 mutation, evolving to tubal precursor lesions, including "p53 signature" and serous tubal intraepithelial carcinoma, and metastasizing to the ovary as clinically evident ovarian cancer. The etiological mechanisms associated with known epidemiological risk factors, i.e., ovulation and retrograde menstruation, have also been suggested. Mutagens and transforming growth factors, such as reactive oxygen species and insulin-like growth factor axis proteins, as well as the apoptosis-rescuing protein hemoglobin are abundantly present in the ovulatory follicular fluid and peritoneum fluid, which bathes the fimbrial epithelium, and induces malignant transformation after repeated exposure. In accordance with the proposed cleansing effect of progesterone from studies on oral contraceptive use or term pregnancy, a recent study indicated that the p53-null tubal epithelial cells are selectively cleared by progesterone depending on its progesterone receptor. In this report, by analyzing different time effects of oral contraceptive use or pregnancy in the prevention of ovarian cancer and by aligning them with the carcinogenic and cleansing clearance concepts of ovulation and progesterone, as well as the fact of progressive loss of progesterone receptor during tubal transformation, we deduced the natural history of ovarian high-grade serous carcinoma. The natural history begins at the first ovulation and spans for more than 30 years, taking 10 years from the normal tubal epithelium to the "p53 signature" status, another 15 years to progesterone receptor negative serous tubal intraepithelial carcinoma, and a final 5+ years to high-grade serous carcinoma. The estimated natural history may help understand the pathogenesis of high-grade serous carcinoma and defines the window for early detection and chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31558785     DOI: 10.1038/s41379-019-0370-1

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma.

Authors:  Xiaoman Hou; Yali Zhai; Kevin Hu; Chia-Jen Liu; Aaron Udager; Celeste L Pearce; Eric R Fearon; Kathleen R Cho
Journal:  Gynecol Oncol       Date:  2022-04-09       Impact factor: 5.304

Review 2.  Etiopathogenesis of ovarian cancer. An inflamm-aging entity?

Authors:  Manuel Sánchez-Prieto; Rafael Sánchez-Borrego; Daniel Maria Lubián-López; Faustino R Pérez-López
Journal:  Gynecol Oncol Rep       Date:  2022-06-11

3.  Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer.

Authors:  Jiahong Tan; Chunyan Song; Daoqi Wang; Yigang Hu; Dan Liu; Ding Ma; Qinglei Gao
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

4.  Human fallopian tube epithelial cells exhibit stemness features, self-renewal capacity, and Wnt-related organoid formation.

Authors:  Yu-Hsun Chang; Tang-Yuan Chu; Dah-Ching Ding
Journal:  J Biomed Sci       Date:  2020-02-08       Impact factor: 8.410

5.  Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation.

Authors:  Hsuan-Shun Huang; Pao-Chu Chen; Sung-Chao Chu; Ming-Hsun Lee; Chi-Ya Huang; Tang-Yuan Chu
Journal:  Neoplasia       Date:  2021-10-21       Impact factor: 5.715

Review 6.  The Double Engines and Single Checkpoint Theory of Endometriosis.

Authors:  Che-Fang Hsu; Aye Aye Khine; Hsuan-Shun Huang; Tang-Yuan Chu
Journal:  Biomedicines       Date:  2022-06-14

Review 7.  The organoid: A research model for ovarian cancer.

Authors:  Yu-Hsun Chang; Kun-Chi Wu; Tomor Harnod; Dah-Ching Ding
Journal:  Tzu Chi Med J       Date:  2021-07-09

8.  Lin28A Regulates Stem-like Properties of Ovarian Cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression.

Authors:  Yancheng Zhong; Lanqin Cao; Haotian Ma; Qian Wang; Pingpin Wei; Juan Yang; Yuqing Mo; Lihua Cao; Cijun Shuai; Shuping Peng
Journal:  Int J Biol Sci       Date:  2020-04-15       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.